Palvella Therapeutics (PVLA) Change in Receivables (2014 - 2025)
Palvella Therapeutics (PVLA) posted quarterly Change in Receivables of -$29000.0 for Q4 2025, up 91.9% quarter-over-quarter from -$358000.0 in Q1 2025.
Palvella Therapeutics (PVLA) Change in Receivables (2014 - 2025) Analysis & Trends
Palvella Therapeutics (PVLA) has reported Change in Receivables for 4 consecutive years, with -$29000.0 the latest figure, recorded in Q4 2025.
- In Q4 2025, Change in Receivables changed N/A year-over-year to -$29000.0; the TTM figure through Dec 2025 stood at -$387000.0 (changed N/A YoY), while the FY2025 annual figure was -$387000.0, changed N/A from the prior year.
- Change in Receivables rose to -$29000.0 in Q4 2025 per PVLA's latest filing, from -$358000.0 in the prior quarter.
- Across five years, Change in Receivables topped out at -$29000.0 in Q4 2025 and bottomed at -$358000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 140.20 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 838.50 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 117.58 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -483,662.49 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 31.60 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 37.16 Mn |
| 10 | Palvella Therapeutics | 2.25 Bn | 1.93 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -29,000.00 |
| Dec 31, 2025 | -29,000.00 |
| Mar 31, 2025 | -358,000.00 |
| Mar 31, 2025 | -358,000.00 |
| Dec 31, 2017 | 12.13 Mn |
| Dec 31, 2017 | 12.13 Mn |
| Sep 30, 2017 | -44.15 Mn |
| Sep 30, 2017 | -44.15 Mn |
| Jun 30, 2017 | 46.50 Mn |
| Jun 30, 2017 | 46.50 Mn |
| Mar 31, 2017 | -19,328.00 |
| Mar 31, 2017 | -19,328.00 |
| Mar 31, 2016 | 68,870.00 |
| Mar 31, 2016 | 68,870.00 |
| Sep 30, 2014 | -474,418.00 |
| Sep 30, 2014 | -474,418.00 |
| Jun 30, 2014 | -68,553.00 |
| Jun 30, 2014 | -68,553.00 |
| Mar 31, 2014 | -479,677.00 |
| Mar 31, 2014 | -479,677.00 |